Related content

Human UDP-Glucuronosyltransferase 2B7

By  

Current Drug Metabolism, Vol. 2, Iss. 3, 2001-09 ,pp. : 283-298

Bentham Science Publishers

Access to resources Recommend Favorite

Screening of non‐steroidal anti‐inflammatory drugs for inhibitory effects on the activities of six UDP‐glucuronosyltransferases (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using LC‐MS/MS

By  

Biopharmaceutics And Drug Disposition, Vol. 36, Iss. 4, 2015-05 ,pp. : 258-264

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells

By Kawai S.   Nishida S.   Kato M.   Furumaya Y.   Okamoto R.   Koshino T.   Mizushima Y.  

European Journal of Pharmacology, Vol. 347, Iss. 1, 1998-04 ,pp. : 87-94

Elsevier

Access to resources Recommend Favorite

The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: the significance for human UGTs from both the 1A and 2B families

By Radominska-Pandya Anna   Bratton Stacie M.   Redinbo Matthew R.   Miley Michael J.  

Drug Metabolism Reviews, Vol. 42, Iss. 1, 2010-02 ,pp. : 133-144

Informa Healthcare

Access to resources Recommend Favorite

Mycophenolic acid glucuronidation and its inhibition by non-steroidal anti-inflammatory drugs in human liver and kidney

By Vietri M.   Pietrabissa A.   Mosca F.   Pacifici G.M.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 659-664

Springer Publishing Company

Access to resources Recommend Favorite